Products

Online Inquiry

As a CRO specializing in cardiovascular disease research, Ace Therapeutics offers a range of inhibitors & activators to study and understand the mechanisms underlying various cardiovascular conditions. These compounds play a crucial role in drug discovery and the development of potential therapies.

Inhibitors & Activators

Cinnarizine (CDIA-0652) Inquiry
Formula:
C26H28N2
CAS Number:
298-57-7
Molecular Weight:
368.51

RF9 (CDIA-0653) Inquiry
Formula:
C26H38N6O3
CAS Number:
876310-60-0
Molecular Weight:
482.62

Safinamide mesylate (CDIA-0654) Inquiry
Formula:
C18H23FN2O5S
CAS Number:
202825-46-5
Molecular Weight:
398.45

GPR30 agonist-1 (CDIA-0655) Inquiry
Formula:
C19H17BrFNO
CAS Number:
415919-74-3
Molecular Weight:
374.25

Nicergoline (CDIA-0656) Inquiry
Formula:
C24H26BrN3O3
CAS Number:
27848-84-6
Molecular Weight:
484.39

Ethamsylate (CDIA-0657) Inquiry
Formula:
C10H17NO5S
CAS Number:
2624-44-4
Molecular Weight:
263.31

Ombrabulin hydrochloride (CDIA-0658) Inquiry
Formula:
C21H27ClN2O6
CAS Number:
253426-24-3
Molecular Weight:
438.90

Acenocoumarol (CDIA-0659) Inquiry
Formula:
C19H15NO6
CAS Number:
152-72-7
Molecular Weight:
353.33

ATWLPPR peptide TFA (CDIA-0660) Inquiry
Formula:
C42H62F3N11O11
Molecular Weight:
954.00

Carteolol hydrochloride (CDIA-0661) Inquiry
Formula:
C16H25ClN2O3
CAS Number:
51781-21-6
Molecular Weight:
328.83

! For research use only. Not intended for any clinical use.